SCHEMBL10688346

SCHEMBL10688346

CCc1nc(-c2ccc(OC)c(OC)c2)cc(=O)n1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ BRD9 Q9H8M2 1/20 0.47
▸ PDE4A P27815 7/20 0.46
▸ PDE4B Q07343 7/20 0.46
▸ PDE4C Q08493 7/20 0.46
▸ PDE4D Q08499 7/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ TDP2 O95551 1/20 0.43
▸ ADORA3 P0DMS8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10686873 0.82 TDP2 (0.49) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10567082 0.82 MEN1 (0.47) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10569897 0.80 GSK3B (0.48) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10567447 0.76 SYK (0.46) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10690149 0.76 KDM4E (0.49) KDM4EALDH1A1MAPTBRD9PDE4A
SCHEMBL10682640 0.75 MAPT (0.43) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10682633 0.75 MAPT (0.43) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10685228 0.73 PDE4A (0.51) KDM4EALDH1A1PDE4APDE4BPDE4C
SCHEMBL10688714 0.72 PDE4A (0.47) KDM4EALDH1A1MAPTPDE4APDE4B
SCHEMBL10683186 0.71 SMN1; SMN2 (0.61) KDM4EALDH1A1MAPTPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4725600-A Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-02-16 — — US disclosed
EP-0168262-A2 Pyrimidine derivatives, processes for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-15 — — EP disclosed
Send feedback